Insmed (INSM) Earnings Analysis

Insmed (INSM) next reports earnings on 2026-08-06, consensus EPS -0.7 USD. Last quarter (2026-05-07) it beat with EPS -0.76 USD vs -0.96338 USD est (+21.1%). It has beaten estimates in 1/7 recent quarters (14%). Trailing P/E -18.55.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does INSM next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate-0.7 USD
Revenue estimate0.39B

INSM earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-0.76 USD-0.96338 USD+21.1%Beat
2026-02-19-1.54 USD-1.07 USD-43.9%Miss
2025-10-30-1.75 USD-1.33 USD-31.6%Miss
2025-05-08-1.42 USD-1.34 USD-6%Miss
2025-02-20-1.32 USD-1.17 USD-12.8%Miss
2024-10-31-1.27 USD-1.2 USD-5.8%Miss
2024-08-08-1.94 USD-1.24 USD-56.5%Miss

Beat rate: 1/7 (14%) over reported quarters with consensus data.

INSM valuation and analyst view

Trailing P/E-18.55
Trailing EPS-5.49388 USD
Price / book32.60
Dividend yield0.00%
Market cap23.01B
Analyst consensusBuy (33 buy / 1 hold / 1 sell)
Avg price target190.86 USD

Related research pages

Frequently asked questions

When is Insmed (INSM)'s next earnings date?

Insmed is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.7 USD and revenue estimate of 0.39B.

Did INSM beat earnings last quarter?

In its 2026-05-07 report, INSM posted EPS of -0.76 USD versus a -0.96338 USD estimate — a beat of 21.1%.

What is INSM's earnings track record?

Over the last 7 reported quarters with consensus data, INSM beat estimates 1 times (14%).

What is INSM's current P/E ratio and EPS?

INSM trades at a trailing P/E of -18.55 on trailing EPS of -5.493878441346279 USD.

What do analysts rate INSM?

Analyst consensus is "Buy" across 35 ratings (0 strong buy, 33 buy, 1 hold, 1 sell, 0 strong sell). Average 12-month price target: 190.86 USD.